ArticleClinical optometry2026
Superficial Keratectomy with Cryopreserved Amniotic Membrane for Ocular Surface Optimization in Patients with Epithelial Basement Membrane Dystrophy.
Article in Clinical optometry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Effect of Preoperative Ocular Surface Optimization on Biometric Accuracy and Refractive Outcomes After Cataract Surgery: A Systematic Review with Narrative and Exploratory Quantitative Synthesis.Clinical ophthalmology (Auckland, N.Z.) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Epithelial Basement Membrane Dystrophy (EBMD)-induced irregular astigmatism can lead to unreliable biometry and suboptimal refractive outcomes in cataract surgery patients. Herein, we assessed the use of superficial keratectomy followed by placement of cryopreserved amniotic membrane (cAM) to improve the ocular surface. Methods: This was a single-center, retrospective study of consecutive patients with EBMD that underwent superficial keratectomy with adjunctive treatment with cAM between November 2022 and March 2025. Time to complete epithelialization, visual acuity (LogMAR), higher order aberration Root Mean Square (HOA RMS), cylinder power, and IOL biometry were assessed up to two months post-treatment. Results: A total of 27 eyes of 21 patients with EBMD were included in the study and received cAM for a mean of 3.0 ± 0.4 days. Complete re-epithelialization was noted in an average 7.0 ± 4.7 days, with 96.3% (26/27) of eyes achieved epithelialization within 10 days. At the two month follow up, LogMAR VA slightly improved from 0.34 ± 0.21 to 0.31 ± 0.23 (p=0.42). HOA RMS significantly improved from 0.68 ± 0.53 μm to 0.42 ± 0.23 μm (p=0.006), and cylinder power significantly changed from 1.38 ± 0.75 D to 1.09 ± 0.71 D (p=0.022). Conclusion: Superficial keratectomy with cAM led to complete re-epithelialization in the majority (96.3%) of cases within 10 days, which was associated with a significant change in HOA RMS, cylinder power and IOL SE. This treatment may be considered in patients prior to cataract surgery to return the cornea to healthy state and change the biometry input for IOL selection.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.